Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy

Clinical trial NCT03920813 · UNKNOWN

Trial details

NCT number: NCT03920813
Sponsor: Shandong University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2015-01-01
Primary completion: 2021-12-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.